Alternatively, a KOR biased-agonist, averting the β-arrestin 2-related signalling mediating dysphoria would be advantageous compared to MOR agonists for pain management and/or prevention of PTSD development, as such agonist could prevent dependency (Spetea and Schmidhammer, 2022). This evidence concerns the gene OPRM1 and post-traumatic stress disorder.